Repligen (RGEN) 2025 Earnings: Outlook & Takeaways
As biotech manufacturing accelerates, repligen (rgen) 2025 earnings will shape how investors price the stock. This gu...
Find value-oriented index funds that maintain low fees in 2024. Understand how value funds can enhance long-term retirement portfolios.
24,728 articlesAs biotech manufacturing accelerates, repligen (rgen) 2025 earnings will shape how investors price the stock. This gu...
Snowflake’s Q4 FY26 results hinge on one key metric—RPO—to gauge AI-driven demand and the strength of its data platfo...
Lemonade posted first positive GAAP free cash flow in the latest quarter, a milestone that reshapes the insurtech nar...
Consensus often feels safe, but it can blind you to turning points. This guide uncovers why consensus fails and offer...
Oracle stock swung wildly last month as AI hype collided with fundamentals. This guide explains what happened, why it...
Occidental Petroleum uses $9.7B from the OxyChem sale to trim debt, boosting cash flow and dividends. Berkshire Hatha...
What could drive Entravision's 2025 earnings, and what should investors watch next? This guide breaks down the driver...
Marvell Technology defied earlier sell-offs tied to fears of losing Amazon and Microsoft to rivals, reporting strong ...
As mega-cap tech pours capital into AI, investors seek signs of durable returns. This piece analyzes which firms stan...
Alphabet's AI ambitions are under scrutiny as cloud momentum and big-capex raise the stakes. Here’s what investors sh...
Mission Produce enters 2026 with a mix of hedges, growing demand, and a tight supply chain. This guide breaks down wh...
Two clean-economy names, two distinct plays: Brookfield Renewable and Clean Harbors offer differing traps and rewards...